BRPI0816789A2 - Goji e inflamação - Google Patents

Goji e inflamação

Info

Publication number: BRPI0816789A2
Authority: BR; Brazil
Prior art keywords: goji; inflammation
Prior art date: 2007-09-12

Application number

Other languages

English (en)

Inventor

Olivier Ballevre

Peter Bucheli

Karine Vidal

Stéphanie Blum-Sperisen

David Philippe

Junkuan Wang

Original Assignee

Nestec Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-12

Filing date

2008-09-12

Publication date

2015-03-17

2008-09-12 Application filed by Nestec Sa filed Critical Nestec Sa

2015-03-17 Publication of BRPI0816789A2 publication Critical patent/BRPI0816789A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Natural Medicines & Medicinal Plants (AREA)
Immunology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Alternative & Traditional Medicine (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Botany (AREA)
Biotechnology (AREA)
Toxicology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Child & Adolescent Psychology (AREA)

BRPI0816789 2007-09-12 2008-09-12 Goji e inflamação BRPI0816789A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07116190A EP2036568A1 (en)	2007-09-12	2007-09-12	Wolfberries and inflammation
PCT/EP2008/062122 WO2009034162A1 (en)	2007-09-12	2008-09-12	Wolfberries and inflammation

Publications (1)

Publication Number	Publication Date
BRPI0816789A2 true BRPI0816789A2 (pt)	2015-03-17

Family

ID=38984201

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816789 BRPI0816789A2 (pt)	2007-09-12	2008-09-12	Goji e inflamação

Country Status (16)

Country	Link
US (2)	US9072769B2 (pt)
EP (3)	EP2036568A1 (pt)
JP (1)	JP2010540415A (pt)
CN (2)	CN103417728A (pt)
AR (1)	AR068448A1 (pt)
AU (1)	AU2008297074A1 (pt)
BR (1)	BRPI0816789A2 (pt)
CA (2)	CA2699233C (pt)
CL (1)	CL2008002692A1 (pt)
ES (1)	ES2698199T3 (pt)
HK (1)	HK1146229A1 (pt)
MX (1)	MX2010002499A (pt)
PT (1)	PT2200624T (pt)
RU (1)	RU2499604C2 (pt)
TW (1)	TW200930389A (pt)
WO (2)	WO2009034165A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1096344A (en) *	1964-04-02	1967-12-29	Sandoz Ltd	Improvements in or relating to organic compounds
TW201021821A (en) *	2008-12-10	2010-06-16	Fl Dauern Res Inc	Formulations and methods for maintaining normal levels of catecholamines, glucocorticoids, androsteroids and their related hormones
CN102639139B (zh) *	2009-09-02	2014-12-17	捷通国际有限公司	用于皮肤修复的组合物和方法
US20110159121A1 (en) *	2009-12-24	2011-06-30	LifeSpan Extension, LLC	Methods and compositions for identifying, producing and using plant-derived products for modulating cell function and aging
MY171851A (en)	2011-06-20	2019-11-04	Heinz Co Brands H J Llc	Probiotic compositions and methods
CN103027879A (zh) *	2011-09-29	2013-04-10	庞来祥	一种具有保湿作用的枸杞唇膏及其制备方法
TR201815457T4 (tr)	2012-04-23	2018-11-21	Univ Oslo	Domates ekstraktının antihipertansif ajan olarak kullanımı ve suda çözünebilen şekersiz domates ekstraktı üretmeye yönelik işlem.
GB201223365D0 (en)	2012-12-24	2013-02-06	Provexis Natural Products Ltd	Compositions
CN105997774A (zh) *	2016-05-10	2016-10-12	芜湖亮晶晶生物科技有限公司	一种止血消炎牙膏及其制备方法
TWI837080B (zh)	2016-11-02	2024-04-01	英商普羅維斯天然產物有限公司	防護空氣汙染之不良影響的水溶性蕃茄萃取物
CN106667937B (zh) *	2017-01-03	2020-01-17	河北省农林科学院经济作物研究所	一种黑枸杞多糖咀嚼片
TWI727584B (zh)	2019-06-20	2021-05-11	財團法人工業技術研究院	抑制皮膚細胞增生及/或抗發炎之組成物以及芹菜素與木犀草素在製備抑制皮膚細胞增生及/或抗發炎之組成物的用途
CN110742883A (zh) *	2019-12-05	2020-02-04	华南农业大学	二氢杨梅素在缓解呕吐毒素引起肠道细胞损伤中的应用
CN112022767B (zh) *	2020-09-17	2023-04-07	云南省药物研究所	一种抗炎抑菌增强免疫祛痘组合物及其应用
US20250049084A1 (en) *	2021-12-20	2025-02-13	Societe Des Produits Nestle S.A.	Process for preparing a berry composition
CN114209810B (zh) *	2022-01-06	2023-02-07	宁夏杞肽科技有限公司	枸杞糖肽在制备用于预防或治疗炎性肠病的药物中的用途
JP7587294B2 (ja)	2022-04-01	2024-11-20	丸善製薬株式会社	正常ヒト歯肉線維芽細胞におけるｉ型コラーゲン産生促進剤及び口腔用剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1100949A (zh) *	1994-03-11	1995-04-05	李启才	金樱保健系列产品及其制法
CN1135338A (zh) *	1995-05-06	1996-11-13	孙秀英	芸杞保健茶
CN1296757A (zh) *	2000-07-09	2001-05-30	鄂来明	芦荟奶制品
JP4713832B2 (ja) *	2001-12-28	2011-06-29	サントリーホールディングス株式会社	２−Ｏ−（β−Ｄ−グルコピラノシル）アスコルビン酸、その製造法、およびそれを含有する組成物を含む食品ならびに化粧品
RU2302879C2 (ru) *	2002-04-09	2007-07-20	Сычуан Институте Оф Чайниз Материа Медика	Фармацевтическая композиция для лечения ревматизма, способ ее приготовления и применение
WO2004043346A2 (en) *	2002-11-08	2004-05-27	Kin-Ping Wong	Compositions containing an active fraction isolated from lycium barbarum and methods of using the same
WO2005018656A1 (ja) *	2003-08-21	2005-03-03	Kaneka Corporation	脳神経細胞死予防及び／または改善剤
EP2251008A1 (en)	2003-12-18	2010-11-17	Unilever Plc, A Company Registered In England And Wales under company no. 41424 of Unilever House	Methods for reducing the effects of stress on skin condition
MY142017A (en)	2004-03-19	2010-08-16	Nestec Sa	Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
US20060024339A1 (en) *	2004-07-29	2006-02-02	Howard Murad	Methods of managing the redness associated with a dermatological condition
US7776915B2 (en) *	2005-03-24	2010-08-17	Tracie Martyn International, Llc	Topical formulations and methods of use
JP2007176814A (ja)	2005-12-27	2007-07-12	Yoshihiro Futamura	炎症性サイトカイン産生抑制作用を有するゼアキサンチン誘導体、それからなる食品製剤、化粧品、抗炎症剤

2007
- 2007-09-12 EP EP07116190A patent/EP2036568A1/en not_active Withdrawn
2008
- 2008-09-10 CL CL2008002692A patent/CL2008002692A1/es unknown
- 2008-09-12 US US12/677,488 patent/US9072769B2/en active Active
- 2008-09-12 US US12/677,978 patent/US20100303741A1/en not_active Abandoned
- 2008-09-12 EP EP08804087A patent/EP2200623A1/en not_active Withdrawn
- 2008-09-12 PT PT08804097T patent/PT2200624T/pt unknown
- 2008-09-12 BR BRPI0816789 patent/BRPI0816789A2/pt not_active IP Right Cessation
- 2008-09-12 CN CN2013102855067A patent/CN103417728A/zh active Pending
- 2008-09-12 TW TW097135292A patent/TW200930389A/zh unknown
- 2008-09-12 AU AU2008297074A patent/AU2008297074A1/en not_active Abandoned
- 2008-09-12 AR ARP080103994A patent/AR068448A1/es not_active Application Discontinuation
- 2008-09-12 CA CA2699233A patent/CA2699233C/en not_active Expired - Fee Related
- 2008-09-12 WO PCT/EP2008/062132 patent/WO2009034165A1/en active Application Filing
- 2008-09-12 WO PCT/EP2008/062122 patent/WO2009034162A1/en active Application Filing
- 2008-09-12 CN CN2008801060708A patent/CN101795699B/zh not_active Expired - Fee Related
- 2008-09-12 ES ES08804097T patent/ES2698199T3/es active Active
- 2008-09-12 CA CA2698860A patent/CA2698860A1/en not_active Abandoned
- 2008-09-12 EP EP08804097.7A patent/EP2200624B1/en active Active
- 2008-09-12 JP JP2010524498A patent/JP2010540415A/ja active Pending
- 2008-09-12 MX MX2010002499A patent/MX2010002499A/es active IP Right Grant
- 2008-09-12 RU RU2010114192/15A patent/RU2499604C2/ru not_active IP Right Cessation
2011
- 2011-01-17 HK HK11100427.0A patent/HK1146229A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
US20100221372A1 (en)	2010-09-02
CA2699233C (en)	2019-03-19
CN101795699B (zh)	2013-07-10
CA2699233A1 (en)	2009-03-19
CN103417728A (zh)	2013-12-04
JP2010540415A (ja)	2010-12-24
ES2698199T3 (es)	2019-02-01
EP2036568A1 (en)	2009-03-18
WO2009034162A1 (en)	2009-03-19
CA2698860A1 (en)	2009-03-19
US9072769B2 (en)	2015-07-07
AU2008297074A1 (en)	2009-03-19
EP2200624B1 (en)	2018-09-05
US20100303741A1 (en)	2010-12-02
RU2010114192A (ru)	2011-10-20
CN101795699A (zh)	2010-08-04
CL2008002692A1 (es)	2009-10-16
MX2010002499A (es)	2010-04-27
EP2200623A1 (en)	2010-06-30
PT2200624T (pt)	2018-11-29
HK1146229A1 (en)	2011-05-20
RU2499604C2 (ru)	2013-11-27
AR068448A1 (es)	2009-11-18
TW200930389A (en)	2009-07-16
EP2200624A1 (en)	2010-06-30
WO2009034165A1 (en)	2009-03-19

Publication	Publication Date	Title
BRPI0816789A2 (pt)	2015-03-17	Goji e inflamação
DK2170827T3 (da)	2013-11-18	Indolin-2-oner og aza-indolin-2-oner
CY2015013I2 (el)	2016-04-13	Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
HK1196358A1 (zh)	2014-12-12	取代的吡啶- -酮和噠嗪- -酮
BRPI0907231A2 (pt)	2019-09-24	pirrolpirimidinas e pirrolpiridinas
BRPI0809978A2 (pt)	2014-10-07	Dispositivos e métodos de dispensação de gotículas
BRPI0812367A2 (pt)	2015-02-03	Dispositivos interoclusais e respectivos métodos de fabrico
DK2185164T3 (da)	2017-11-13	Sammensætning og terapeutisk antitumorvaccine
DK2185552T3 (da)	2014-06-10	Dipeptoid-prodrugs og anvendelse heraf
DE602007010795D1 (de)	2011-01-05	Blattsauger und -häcksler
DK2220320T3 (da)	2019-11-04	Forseglet enhed og mellemstykke
DE112007000086A5 (de)	2010-10-14	Verbindungselement sowie Verbindungsanordnung
EP2147614A4 (en)	2012-09-12	DISPLAY SYSTEM
DK2118140T3 (da)	2013-07-01	Humancytomegalovirus-neutraliserende antistoffer og anvendelse deraf
BRPI0810497A2 (pt)	2015-07-21	Refrigerador e dispositivo elétrico
BRPI0810142A2 (pt)	2014-11-25	Intercalação dinâmica de fluxos e entrega baseada em subfluxos
BRPI0813647A2 (pt)	2014-12-23	Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
FI20075881L (fi)	2009-06-06	Lääketieteellinen väline ja sen valmistus
DK2160336T3 (da)	2013-07-22	Forbindelsesmekanisme og fremgangsmåde
DK2086213T3 (da)	2010-10-18	Billedlæseapparat og billeddannelseapparat
BRPI0815203A2 (pt)	2017-03-28	gel contendo pirfenidona
FR2924738B1 (fr)	2012-11-09	Charniere
EP2222427A4 (en)	2011-03-09	GRID INSERT
FI20075686A0 (fi)	2007-09-28	Konfigurointimenetelmä ja -laite
BRPI0821351A2 (pt)	2019-09-24	aparelhos e métodos

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application fees: dismissal - article 86 of industrial property law	Free format text: REFERENTE A 7A ANUIDADE.
2016-04-05	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.